Lijuan Liu

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Magnetic Resonance

Top Venues

Molecular pharmaceutics

International journal of nanomedicine

This page only lists publications with an associated author ORCID identifier.

Publications

Haonan Tang, Xiao Zhou, Lijuan Liu, Ziyu Wang, Chen Wang, Ningbin Luo, Guanqiao Jin
Superparamagnetic Iron Oxide-Erastin-Polyethylene Glycol Nanotherapeutic Platform: A Ferroptosis-Based Approach for the Integrated Diagnosis and Treatment of Nasopharyngeal Cancer. Molecular pharmaceutics 21 (6) (2024)
Haonan Tang, Xiao Zhou, Lijuan Liu, Ziyu Wang, Chen Wang, Ningbin Luo, Guanqiao Jin
Superparamagnetic Iron Oxide-Erastin-Polyethylene Glycol Nanotherapeutic Platform: A Ferroptosis-Based Approach for the Integrated Diagnosis and Treatment of Nasopharyngeal Cancer. Molecular pharmaceutics 21 (6) (2024)
Ting Li, Lianshan Guo, Jiaxu Li, Xingyu Mu, Lijuan Liu, Shulin Song, Ningbin Luo, Qi Zhang, Bin Zheng, Guanqiao Jin
Precision USPIO-PEG-SLe x Nanotheranostic Agent Targeted Photothermal Therapy for Enhanced Anti-PD-L1 Immunotherapy to Treat Immunotherapy Resistance. International journal of nanomedicine 19 (2024)
Haonan Tang, Xiao Zhou, Lijuan Liu, Ziyu Wang, Chen Wang, Ningbin Luo, Guanqiao Jin
Superparamagnetic Iron Oxide-Erastin-Polyethylene Glycol Nanotherapeutic Platform: A Ferroptosis-Based Approach for the Integrated Diagnosis and Treatment of Nasopharyngeal Cancer. Molecular pharmaceutics (2024)
Ting Li, Lianshan Guo, Jiaxu Li, Xingyu Mu, Lijuan Liu, Shulin Song, Ningbin Luo, Qi Zhang, Bin Zheng, Guanqiao Jin
Precision USPIO-PEG-SLe x Nanotheranostic Agent Targeted Photothermal Therapy for Enhanced Anti-PD-L1 Immunotherapy to Treat Immunotherapy Resistance. International journal of nanomedicine 19 (2024)